Chargement en cours...
Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method
Isavuconazole is a novel expanded-spectrum triazole, which has recently been approved by the FDA as an orphan drug to treat invasive aspergillosis and is currently being studied in phase III clinical trials for invasive candidiasis. The susceptibility of relatively few clinical isolates has been rep...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3811258/ https://ncbi.nlm.nih.gov/pubmed/23959309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01111-13 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|